| Literature DB >> 35589795 |
J Heukamp1, H Korbmacher-Steiner1, S Schmidt1, C M Neumann1, P Bottenberg2, A Jablonski-Momeni3.
Abstract
Enamel demineralisation can develop on smooth surfaces as an undesirable side effect during orthodontic treatment with fixed appliances. This study aimed to evaluate the ability of 38% silver diamine fluoride in remineralisation (as estimated by fluorescence gain) of artificial initial lesions in smooth surfaces of human enamel. The smooth surfaces of 50 human tooth samples were artificially demineralised and 45 samples were allocated randomly into three groups receiving a single treatment with a varnish: group I: Riva Star (silver diamine fluoride, SDF), group II: Bifluorid 12 (NaF, CaF2), and group III: Cervitec F (CHX, CPC, NH4F). Five samples were assigned as a negative control group without treatment. All samples were exposed to pH-cycling for 28 days. Fluorescence behavior was measured using Quantitative light-induced fluorescence before and after demineralisation and up to four weeks on a weekly basis. Analysis of variance (ANOVA) with Tukey-Kramer post-hoc tests and repeated measures ANOVA were used for statistical evaluation (α = 0.05). After demineralisation, all samples showed mean ΔF of - 16.22% ± 4.35, without significance differences between the fluorescence behaviour of the samples (p = 0.251). After 28 days group comparison showed a statistically significant difference (p = 0.034) for ΔF values: the lowest fluorescence values were found in group I (SDF, mean ΔF - 16.47 ± 6.08) with a significant difference compared to group III (Cervitec F, mean ΔF - 11.71 ± 4.83). In group II (Bifluorid 12) mean ΔF value was - 15.55 ± 2.15) without statistically significant differences to groups I and III. The fluorescence behaviour of SDF varnish on smooth surfaces with artificial initial enamel lesions was significantly lower compared to Cervitec F varnish after short time use.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35589795 PMCID: PMC9120108 DOI: 10.1038/s41598-022-12498-6
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.996
Results of the QLF measurements in different groups: ΔF (fluorescence loss [%]) shows avarage fluorescence loss in a lesion and is related to the loss of mineral content and to lesion depth (SD: standard deviation).
| Time | Group | Minimum | Maximum | Mean | SD | Group comparison |
|---|---|---|---|---|---|---|
ΔF T-demin | I: SDF | − 21.3 | − 8.1 | − 16.65 | 4.13 | |
| II: Bifluorid 12 | − 22.7 | − 7.2 | − 15.38 | 4.70 | ||
| III: Cervitec F | − 23.8 | − 10.0 | − 17.56 | 4.16 | ||
| Negative control | − 19.1 | − 10.1 | − 13.46 | 3.89 | ||
| ΔF T07 | I: SDF | − 21.8 | − 8.4 | − 14.16 | 3.94 | |
| II: Bifluorid 12 | − 30.5 | − 10.5 | − 17.88 | 4.89 | ||
| III: Cervitec F | − 24.1 | − 8.1 | − 15.88 | 4.13 | ||
| ΔF T14 | I: SDF | − 23.1 | − 8.6 | − 15.53 | 4.42 | |
| II: Bifluorid 12 | − 30.9 | − 12.6 | − 19.40 | 5.19 | ||
| III: Cervitec F | − 21.9 | − 7.4 | − 15.97 | 4.56 | ||
| ΔF T21 | I: SDF | − 31.3 | − 8.6 | − 16.17 | 6.81 | |
| II: Bifluorid 12 | − 27.1 | − 12.1 | − 18.81 | 4.12 | ||
| III: Cervitec F | − 22.0 | − 8.9 | − 15.08 | 3.81 | ||
| ΔF T28 | I: SDF | − 33.0 | − 9.9 | − 16.47a | 6.08 | |
| II: Bifluorid 12 | − 20.0 | − 12.4 | − 15.55a,b | 2.15 | ||
| III: Cervitec F | − 22.9 | − 6.3 | − 11.71b | 4.83 | ||
| Negative control | − 20.2 | − 12.6 | − 15.40a,b | 3.20 |
*Different superscript letters indicate significant differences between the groups.
Results of the QLF measurements in different groups: ΔF max (fluorescence loss [%]) shows the highest value of ΔF measured within the region of interest and is an indication for the maximum lesion depth (SD: standard deviation).
| Time | Group | Minimum | Maximum | Mean | SD | Group comparison |
|---|---|---|---|---|---|---|
ΔFmax T-demin | I: SDF | − 45.8 | − 20.3 | − 33.97 | 6.75 | |
| II: Bifluorid 12 | − 41.4 | − 13.2 | − 30.69 | 7.94 | ||
| III: Cervitec F | − 50.3 | − 26.4 | − 35.51 | 6.07 | ||
| Negative control | − 40.1 | − 30.5 | − 33.56 | 3.89 | ||
| ΔFmax T07 | I: SDF | − 44.8 | − 22.0 | − 33.17 | 6.55 | |
| II: Bifluorid 12 | − 49.6 | − 27.5 | − 37.66 | 6.87 | ||
| III: Cervitec F | − 43.5 | − 20.7 | − 34.32 | 5.86 | ||
| ΔFmax T14 | I: SDF | − 50.0 | − 28.6 | − 37.96a,b | 8.07 | |
| II: Bifluorid 12 | − 50.0 | − 30.2 | − 40.41a | 6.20 | ||
| III: Cervitec F | − 40.0 | − 19.3 | − 33.01b | 6.91 | ||
| ΔFmax T21 | I: SDF | − 59.5 | − 21.2 | − 39.23 | 11.60 | |
| II: Bifluorid 12 | − 61.8 | − 28.6 | − 39.89 | 8.32 | ||
| III: Cervitec F | − 41.0 | − 19.4 | − 33.18 | 6.14 | ||
| ΔFmax T28 | I: SDF | − 52.4 | − 26.8 | − 38.14a | 8.71 | |
| II: Bifluorid 12 | − 50.9 | − 26.2 | − 34.53a | 6.37 | ||
| III: Cervitec F | − 46.8 | − 9.80 | − 24.24b | 9.98 | ||
| Negative control | − 45.2 | − 30.6 | − 34.98a,b | 6.00 |
*Different superscript letters indicate significant differences between the groups.
Figure 1Standard image and QLF image of a representative sample in group I (SDF, sample #05) at different investigation times. The dashed line indicates the ground surface where the QLF measurements were performed. (a) Prior to demineralization. (b) Corresponding QLF-image: ΔF = 0.0%; ΔFmax = 0.0%. (c) After demineralisation (T-demin). (d) Corresponding QLF-image (T-demin): ΔF = − 17.0%; ΔFmax = − 34.1%. (e) QLF image T07: ΔF = − 12.2%; ΔFmax = − 28.6%. (f) QLF image T14: ΔF = − 12.8%; ΔFmax = − 30.2%. (g) QLF image T21: ΔF = − 11.5%; ΔFmax = − 33.3%. (h) 28 days after demineralisation (T28). (i) Corresponding QLF-image (T28): ΔF = − 14.5%; ΔFmax = − 30.2%.
Figure 2Standard image and QLF image of a representative sample in group II (Bifluorid 12, sample #12) at different investigation times. The dashed line indicates the ground surface where the QLF measurements were performed. (a) Prior to demineralisation. (b) Corresponding QLF-image: ΔF = 0.0%; ΔFmax = 0.0%. (c) After demineralisation (T-demin). (d) Corresponding QLF-image (T-demin): ΔF = − 11.3%; ΔFmax = − 20.9%. (e) QLF image T07: ΔF = − 17.7%; ΔFmax = − 36.7%. (f) QLF image T14: ΔF = − 17.1%; ΔFmax = − 36.2%. (g) QLF image T21: ΔF = − 13.3%; ΔFmax = − 30.1%. (h) 28 days after demineralisation (T28). (2i) Corresponding QLF-image (T28): ΔF = − 15.7%; ΔFmax = − 34.2%.
Figure 3Standard image and QLF image of a representative sample in group III (Cervitec F, sample #09) at different investigation times. The dashed line indicates the ground surface where the QLF measurements were performed. (3a) Prior to demineralization. (b) Corresponding QLF-image: ΔF = 0.0%; ΔFmax = 0.0%. (c) After demineralisation (T-demin). (d) Corresponding QLF-image (T-demin): ΔF = ΔF = − 16.5%; ΔFmax = − 30.5%. (e) QLF image T07: ΔF = − 14.7%; ΔFmax = − 27.1%. (f) QLF image T14: ΔF = − 8.9%; ΔFmax = − 19.8%. (g) QLF image T21: ΔF = − 9.8%; ΔFmax = − 19.4%. (h) 28 days after demineralisation (T28). (i) Corresponding QLF-image (T28): ΔF = − 6.3%; ΔFmax = − 9.8%.
Figure 4Standard image and QLF image of a representative sample in the negative control group (no treatment, sample #09) at different investigation times. The dashed line indicates the ground surface where the QLF measurements were performed. (a) Prior to demineralisation. (b) Corresponding QLF-image: ΔF = 0.0%; ΔFmax = 0.0%. (c) After demineralisation (T-demin). (d) Corresponding QLF-image (T-demin): ΔF = − 10.4%; ΔFmax = − 33.7%. (e) 28 days after demineralisation (T28). (f) Corresponding QLF-image (T28): ΔF = − 12.6%; ΔFmax = − 33.5%.